drugset / Trial / NCT06681662

Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients

NCT06681662

Phase 4 Recruiting 80 enrolled Matias Vested
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to determine the onset time of rocuronium after administration of ephedrine 0.15 mg/kg in patients with age ≥ 80 years. The hypothesis of this study is that ephedrine 0.15 mg/kg provides a shorter onset time compared to placebo (saline).

Timeline

Start
2025-01-13
Primary completion
2025-09
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ephedrine Small molecule 0.15 mg/kg

Indications

No indication recorded.